Home / News / First USPP under Belgian law for Biobest

First USPP under Belgian law for Biobest

CMS, Torys and Morgan Lewis advise Pricoa Private Capital on the deal

07/02/2022

Biobest, a world leader in pollination and integrated biological control, has successfully issued its first USPP governed by Belgian law, which was subscribed by Pricoa Private Capital, a leading U.S. institutional investor.

This private placement denominated in Canadian dollars, with a 10-year maturity, was carried out on the basis of USPP documentation that is consistent with that used in the U.S. market, while being governed by Belgian law.

This transaction aims to finance the acquisition of Plant Products in Canada by Biobest.

For this transaction, the teams of CMS (France, Belgium and the Netherlands), Torys LLP (Canada) and Morgan, Lewis & Bockius LLP (US), coordinated by Marc-Etienne Sébire, Partner and Head of Capital Markets for CMS France, comprised:

  • CMS France: Marc-Etienne Sébire, partner, and Myriam Issad and Pierre Maunand, associates, for Capital Markets matters;
  • CMS Belgique: Benoît Vandervelde, partner, and Florence Berchem, associate, for Capital Markets matters, and Olivier Querinjean, partner, and Arnout Vaninbroukx, associate, for Tax matters;
  • CMS Netherlands: Clair Wermers, partner, Etiënne Courbois, counsel, and Mathijs van der Veen, associate, for Capital Markets matters;
  • Torys LLP: David Seville, partner, and Michael Jason and Danielle Marjoram, associates, for Capital Markets matters, and Andrew Wong, partner, for Tax matters; and
  • Morgan, Lewis & Bockius LLP: Tori Weir, partner, for Capital Markets matters.

Biobest was advised by Jones Day and Stikeman Elliott LLP.

Related people

Portrait ofMarc-Etienne-Sébire VDEF
Marc-Etienne Sébire
Partner
Paris
Portrait ofMyriam Issad
Myriam Issad
Associate
Paris
Portrait ofPierre Maunand
Pierre Maunand
Associate
Paris